These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9471725)

  • 21. NIH plans probe on test of altered virus.
    Sun M
    Science; 1986 May; 232(4752):821-2. PubMed ID: 3704629
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant DNA Advisory Committee: minutes of meeting, 14 Jan 1993.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1993 Aug; 4(4):529-44. PubMed ID: 11643161
    [No Abstract]   [Full Text] [Related]  

  • 23. Animal advisors forced into the open.
    Kleiner K
    New Sci; 1997 Jan; 153(2066):9. PubMed ID: 11656576
    [No Abstract]   [Full Text] [Related]  

  • 24. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 25. Minutes of meeting of the Recombinant DNA Advisory Committee, 30 Mar 1990.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 1990; 1(4):493-501. PubMed ID: 11642816
    [No Abstract]   [Full Text] [Related]  

  • 26. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant DNA research: proposed actions under the guidelines.
    U.S. National Institutes of Health
    Fed Regist; 1997 Aug; 62(161):44387-90. PubMed ID: 11658086
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant DNA research: notice of intent to propose amendments to the NIH Guidelines for research involving recombinant DNA molecules (NIH Guidelines) regarding enhanced mechanisms for NIH oversight of recombinant DNA activities.
    U.S. National Institutes of Health
    Fed Regist; 1996 Jul; 61(131):35774-7. PubMed ID: 11654428
    [No Abstract]   [Full Text] [Related]  

  • 29. Remarks for the RAC Committee meeting of January 14, 1993, regarding compassionate use exemption.
    Healy B
    Hum Gene Ther; 1993 Apr; 4(2):195-7. PubMed ID: 8494929
    [No Abstract]   [Full Text] [Related]  

  • 30. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS test involving baboon is approved.
    Altman LK
    N Y Times Web; 1995 Jul; ():7. PubMed ID: 11647078
    [No Abstract]   [Full Text] [Related]  

  • 32. Xenotransplant caution continues.
    Nature; 1999 Apr; 398(6728):543. PubMed ID: 10217127
    [No Abstract]   [Full Text] [Related]  

  • 33. Does biomedical research need another moratorium?
    Nat Med; 1998 Feb; 4(2):131. PubMed ID: 9461163
    [No Abstract]   [Full Text] [Related]  

  • 34. Petition to amend the National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules to establish a Public Policy Advisory Committee. Foundation on Economic Trends, September 18, 1990.
    Hum Gene Ther; 1991; 2(2):131-4. PubMed ID: 1911933
    [No Abstract]   [Full Text] [Related]  

  • 35. The standard of disclosure in human subject experimentation.
    Morin K
    J Leg Med; 1998 Jun; 19(2):157-221. PubMed ID: 9658739
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioethical catch-22: the moratorium on federal funding of fetal tissue transplantation research and the NIH revitalization amendments.
    Maroney HM
    J Contemp Health Law Policy; 1993; 9():485-519. PubMed ID: 10126947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 38. Conflict at the RAC.
    Culliton BJ
    Science; 1990 Apr; 298(4952):159. PubMed ID: 11653881
    [No Abstract]   [Full Text] [Related]  

  • 39. Proposal for a coordinated framework for regulation of biotechnology.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
    [No Abstract]   [Full Text] [Related]  

  • 40. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.